These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11510963)

  • 21. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.
    Sterman DH; Treat J; Litzky LA; Amin KM; Coonrod L; Molnar-Kimber K; Recio A; Knox L; Wilson JM; Albelda SM; Kaiser LR
    Hum Gene Ther; 1998 May; 9(7):1083-92. PubMed ID: 9607419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy.
    Izquierdo M; Cortés M; de Felipe P; Martín V; Díez-Guerra J; Talavera A; Perez-Higueras A
    Gene Ther; 1995 Jan; 2(1):66-9. PubMed ID: 7712334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
    Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
    Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
    Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of rat gliomas with recombinant retrovirus harboring Herpes simplex virus thymidine kinase suicide gene.
    Hlavatý J; Hlubinová K; Altanerová V; Líska J; Altaner C
    Neoplasma; 1997; 44(6):342-7. PubMed ID: 9605005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gene therapy of cerebral glioblastoma by adenovirus vector. Experimental model in the rat].
    Dufour T; Quillien V; Heresbach N; Denais A; Ferry N; Guegan Y
    Chirurgie; 1998 Apr; 123(2):168-74. PubMed ID: 9752539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
    Paquin A; Jaalouk DE; Galipeau J
    Hum Gene Ther; 2001 Jan; 12(1):13-23. PubMed ID: 11177538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
    Staquicini FI; Smith TL; Tang FHF; Gelovani JG; Giordano RJ; Libutti SK; Sidman RL; Cavenee WK; Arap W; Pasqualini R
    Cancer Gene Ther; 2020 May; 27(5):301-310. PubMed ID: 31130731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical protocol. Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme.
    Voges J; Weber F; Reszka R; Sturm V; Jacobs A; Heiss WD; Wiestler O; Kapp JF
    Hum Gene Ther; 2002 Mar; 13(5):675-85. PubMed ID: 11916490
    [No Abstract]   [Full Text] [Related]  

  • 33. Are hepatomas a good target for suicide gene therapy? An experimental study in rats using retroviral-mediated transfer of thymidine kinase gene.
    Nagy H; Panis Y; Fabre M; Perrin H; Klatzmann D; Houssin D
    Surgery; 1998 Jan; 123(1):19-24. PubMed ID: 9457219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy in brain tumours: implications of the size of glioblastoma on its curability.
    Izquierdo M; Cortés ML; Martín V; de Felipe P; Izquierdo JM; Pérez-Higueras A; Paz JF; Isla A; Blázquez MG
    Acta Neurochir Suppl; 1997; 68():111-7. PubMed ID: 9233425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
    Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model.
    Oh B; Han J; Choi E; Tan X; Lee M
    J Pharm Sci; 2015 Apr; 104(4):1461-9. PubMed ID: 25631673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.
    Kruse CA; Roper MD; Kleinschmidt-DeMasters BK; Banuelos SJ; Smiley WR; Robbins JM; Burrows FJ
    Cancer Gene Ther; 1997; 4(2):118-28. PubMed ID: 9080121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.
    Goebel EA; Davidson BL; Graham SM; Kern JA
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene.
    Elshami AA; Kucharczuk JC; Sterman DH; Smythe WR; Hwang HC; Amin KM; Litzky LA; Albelda SM; Kaiser LR
    Ann Surg; 1995 Sep; 222(3):298-307; 307-10. PubMed ID: 7677460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.